Christopher Allan Dobry D P M is categorized under Podiatrists in Frisco, TX and active since 2004.
Christopher Allan Dobry D P M was established in 2004, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Podiatrists business, which does work in the B2C market, and is classified as a Podiatrists, under code number 621391 by the NAICS.
If you are seeking more information, feel free to contact Christopher Dobry at the company’s single location by writing to 3550 Parkwood Boulevard # 703, Frisco, Texas TX 75034 or by phoning (214) 618-3750. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Christopher Allan Dobry D P M |
Contact Person: | Christopher Dobry |
Address: | 3550 Parkwood Boulevard # 703, Frisco, Texas 75034 |
Phone Number: | (214) 618-3750 |
Website Address: | friscofootcare.com |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2004 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Podiatrists |
SIC Code: | 8043 |
NAICS Code: | 621391 |
Share This Business: |
Christopher Allan Dobry D P M was started in 2004 to provide professional Podiatrists under the SIC code 8043 and NAICS code 621391. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Christopher Dobry for inquiries that concern Christopher Allan Dobry D P M by calling the company number (214) 618-3750, as your correspondence is most welcome. Additionally, the physical location of the single location of Christopher Allan Dobry D P M can be found at the coordinates 33.109384,-96.816275 as well as the street address 3550 Parkwood Boulevard # 703 in Frisco, Texas 75034.
For its online presence, you may visit Christopher Allan Dobry D P M’s website at friscofootcare.com and engage with its social media outlets through on Twitter and on Facebook.